Evofem Biosciences PE Ratio 2013-2022 | EVFM
Current and historical p/e ratio for Evofem Biosciences (EVFM) from 2013 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Evofem Biosciences PE ratio as of May 20, 2022 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Evofem Biosciences PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2022-05-23 |
0.41 |
|
0.00 |
| 2022-03-31 |
5.10 |
$-19.07 |
0.00 |
| 2021-12-31 |
5.63 |
$-24.59 |
0.00 |
| 2021-09-30 |
11.08 |
$-27.14 |
0.00 |
| 2021-06-30 |
16.95 |
$-25.49 |
0.00 |
| 2021-03-31 |
26.25 |
$-35.08 |
0.00 |
| 2020-12-31 |
36.15 |
$-32.68 |
0.00 |
| 2020-09-30 |
35.40 |
$-29.24 |
0.00 |
| 2020-06-30 |
42.45 |
$-28.19 |
0.00 |
| 2020-03-31 |
79.80 |
$-29.09 |
0.00 |
| 2019-12-31 |
92.55 |
$-33.13 |
0.00 |
| 2019-09-30 |
75.60 |
$-37.78 |
0.00 |
| 2019-06-30 |
99.60 |
$-43.93 |
0.00 |
| 2019-03-31 |
52.50 |
$-46.03 |
0.00 |
| 2018-12-31 |
62.85 |
$-105.25 |
0.00 |
| 2018-09-30 |
60.75 |
$-96.55 |
0.00 |
| 2018-06-30 |
40.65 |
$-97.60 |
0.00 |
| 2018-03-31 |
95.25 |
$-98.94 |
0.00 |
| 2017-12-31 |
175.50 |
$-49.47 |
0.00 |
| 2017-09-30 |
42.30 |
$-62.06 |
0.00 |
| 2017-06-30 |
48.60 |
$-65.65 |
0.00 |
| 2017-03-31 |
144.00 |
$-64.75 |
0.00 |
| 2016-12-31 |
100.80 |
$-84.54 |
0.00 |
| 2016-09-30 |
100.80 |
$-134.01 |
0.00 |
| 2016-06-30 |
88.19 |
$-232.04 |
0.00 |
| 2016-03-31 |
54.90 |
$-277.01 |
0.00 |
| 2015-12-31 |
125.10 |
$-282.40 |
0.00 |
| 2015-09-30 |
726.30 |
$-260.82 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.005B |
$0.008B |
|
Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.
|
